2022
DOI: 10.1210/clinem/dgac081
|View full text |Cite
|
Sign up to set email alerts
|

Ambulatory Blood Pressure Monitoring in Children and Adults Prenatally Exposed to Dexamethasone Treatment

Abstract: Background The clinical use of dexamethasone (DEX) prenatally to reduce virilization of external genitalia in female fetuses with congenital adrenal hyperplasia (CAH) is efficient but still controversial. It remains challenging to prevent the excessive exposure of DEX in unborn healthy babies during the first trimester of pregnancy. Since endogenous glucocorticoids (GC) contribute to the maintenance of blood pressure (BP) and since events during fetal life may program the fe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
1
1
2

Year Published

2022
2022
2023
2023

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 48 publications
0
1
1
2
Order By: Relevance
“…The numbers of unaffected subjects treated with DEX are substantially larger and hence easier to perform meaningful statistical analyses. Although height, weight, BMI, heart rate and blood pressure were comparable between DEX-treated participants and population controls ( 104 , 105 ), we did find differences in terms of beta cell function in the Swedish cohort ( 105 ). Indeed, in our child–adult cohort, age 5–26 years, DEX-treated healthy subjects ( n = 40) had lower HOMA-B index compared to controls, which was only the case for girls ( n = 18).…”
Section: Outcomes Of Prenatal Dex Treatment In Cahcontrasting
confidence: 61%
“…The numbers of unaffected subjects treated with DEX are substantially larger and hence easier to perform meaningful statistical analyses. Although height, weight, BMI, heart rate and blood pressure were comparable between DEX-treated participants and population controls ( 104 , 105 ), we did find differences in terms of beta cell function in the Swedish cohort ( 105 ). Indeed, in our child–adult cohort, age 5–26 years, DEX-treated healthy subjects ( n = 40) had lower HOMA-B index compared to controls, which was only the case for girls ( n = 18).…”
Section: Outcomes Of Prenatal Dex Treatment In Cahcontrasting
confidence: 61%
“…Ïîÿâà äåôåêò³â åíäîòåë³þ ó öèõ ì³ñöÿõ ïðèçâîäèòü äî ³í³ö³àö³¿ îêñèäàòèâíîãî ñòðåñó òà çàïàëüíèõ ïðîöåñ³â [1]. ³äîìî, ùî ñòðåñ ìîaeå ïðèçâîäèòè äî òðàíçèòîðíîãî ï³äâèùåííÿ ÀÒ [2,3]. Íå âèâ-÷åíî äîñòàòíüî, ÿêî¿ ñàìå ïðèðîäè ïîäðàçíèê ìຠáóòè, ÿê äîâãî â³í ìຠä³ÿòè, ùîá ïðèçâåñòè äî çíà÷íèõ íàñë³äê³â, ÿê âèçíà÷èòè ñà-Material and Methods.…”
Section: âñòóïunclassified
“…Відомо, що стрес може призводити до транзиторного підвищення АТ [4,5], але питання, чи може гострий стресорний подразник достатньої сили призвести до постійно підвищеного АТ (тобто до АГ), ще залиша-ється предметом дискусій [6]. Не вивчено достатньо, якої саме природи подразник має бути, як довго він має діяти, щоб призвести до значних наслідків, як визначити саме його зв'язок із підвищенням АТ або ж як оцінити кількісно його силу [7,8].…”
Section: вступunclassified